Abstract
Modulation of the Gut-Skin Axis and Inflammatory Processes in Acne: a Review of Molecular Mechanisms and Therapeutic Perspectives using Probiotics
KKS Statistics, Ruda Slaska, Poland
Barbara Provincial Specialist Hospital No. 5, Sosnowiec, Poland
Regional Specialist Hospital of Our Lady, Czestochowa, Poland
Regional Hospital, Poznan, Poland
Pope John Paul II Independent Public Provincial Hospital, Zamosc, Poland
District Hospital, Zawiercie, Poland
Dermatol Rev/Przegl Dermatol 2026, 113, 225–230
Acne vulgaris is a chronic inflammatory skin disease which can be linked to dysbiosis of the skin and also the gut microbiome, involving the proliferation of Cutibacterium acnes and excessive sebum secretion. The gut-skin axis is a critical regulator of cutaneous immune response and inflammation. Our review highlights that the link between gut dysbiosis and skin pathological processes is mediated by short-chain fatty acids, which are microbiota-derived metabolites. Clinical evidence demonstrates that oral supplementation with Lactobacillus and Bifidobacterium strains reduces lesion count, regulates sebum secretion, and modulates inflammation. Furthermore, topical probiotics support the epidermal barrier integrity, compete with pathogens, and aid tissue regeneration. Probiotic and postbiotic strategies offer a compelling, mechanism-driven approach to acne therapy.
Keywords
acne vulgaris, probiotics, gastrointestinal microbiome, fatty acids, nuclear factor-κB
Coverage in
Integrated with

